New gene therapy may allow patients to 'grow' their own bypass around blocked leg arteries

PHILADELPHIA - Temple University Hospital's Center for Vascular Disease has initiated Phase I clinical trials to test in humans a new gene therapy that may have the potential to help the body grow new blood vessels to create a bypass around blocked leg arteries.

Temple is participating in the trial to determine the safety and tolerability of the therapy to treat patients with severe peripheral arterial occlusive disease (PAOD), or critical limb ischemia. The therapy encodes the FGF1 gene, an angiogenic growth factor. The study is sponsored by RPR Gencell, the gene therapy division of Rhône-Poulenc Rorer.

"The growth factor gene, which will be injected into the leg muscles of study participants, will be studied to document its safety and, secondarily, its ability to cause the formation of new blood vessels in limbs with blocked arteries," says Dr. Anthony J. Comerota, section chief of vascular surgery at Temple, director of the Center for Vascular Disease and lead investigator of the study.

According to Comerota, if new vessels are formed, they may create a natural bypass around blocked arteries in patients who have no other alternative for restoring circulation to their leg, and are facing a high risk for amputation. Investigators hope that the additional blood flow will reduce pain and numbness, heal wounds, and restore damaged tissue on the feet and legs.

People who suffer from severe PAOD of the legs often experience severe pain even while at rest as well as chronic wounds that won't heal, numbness, a burning sensation in their lower limbs, and gangrene that can lead to amputation. Traditionally, physicians attempt to treat these patients with surgical bypass/revascularization and angioplasty. In many cases, however, these procedures cannot be applied. Drug therapy is also ineffective for severe PAOD. Amputation of the lower leg is often the only solution for a large number of patients.


Contact: Leslie Miller
Cooney Waters Group, Inc.

Page: 1 2

Related medicine news :

1. Study shows patch therapy may be as effective as oral medications
2. Novel therapy tested in mice could chase away cat allergies
3. Drug therapy may be comparable to invasive cardiac procedures for elderly patients with heart attack
4. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
5. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
6. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
7. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
8. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
9. Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients
10. Cognitive behavioral therapy and medication is effective in the treatment of panic disorder
11. Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis

Post Your Comments:

(Date:9/12/2019)... Ohio (PRWEB) , ... September 12, 2019 , ... ... on both a local and national scale in two recent and well-renowned listing ... country’s fastest-growing privately held businesses for the 2019 year. , Dr. Jeffrey ...
(Date:9/11/2019)... , ... September 11, 2019 , ... ... and an accredited continuing medical education (CME) provider, is the official accreditor for ... reviewed presentations, vetted speakers, and screened topics, as it has done for the ...
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... Autopsies don’t ... damage or injury to the body. , Methamphetamine permanently harms the heart. It ... doctors are getting a better understanding of how the damage occurs. , ...
(Date:9/11/2019)... ... 2019 , ... Women’s Excellence is excited to announce the opening of their ... Suite 103, Royal Oak, MI 48073 in the heart of Royal Oak off Woodward ... services in a contemporary, spa-like atmosphere. We are thrilled to be in a ...
(Date:9/11/2019)... ... September 10, 2019 , ... Episcopal Relief & Development is ... impacted by Hurricane Dorian. , In partnership with the Episcopal Diocese of ... and the Episcopal Farmworker Ministry, Episcopal Relief & Development is giving assistance such ...
Breaking Medicine News(10 mins):
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... ... R&D, today announced Orion Pharma, a globally operating Finnish pharmaceutical company, has licensed ... nervous system, and other medical indications. , “As part of our strategy ...
(Date:9/11/2019)... ... September 11, 2019 , ... The Telehealth Secrets conference announces ... Naveen Jain, MDLIVE founder Randy Parker, NBC Comcast, senior vice president and general ... 4th Annual Telehealth Secrets conference brings together nationally recognized health innovators, thinkers, and ...
(Date:9/11/2019)... ... September 11, 2019 , ... HOLLOWAY AMERICA, a leading manufacturer of ... to pharma and chemical, recently announced it will showcase its problem-solving vessels and tanks ... , HOLLOWAY AMERICA’s first stop will be at ISPE San Diego’s 27th Life Science ...
Breaking Medicine Technology:
Cached News: